Mycobacterial diseases, most notably tuberculosis and infections from environmental mycobacteria, represent a significant global health challenge. Their clinical severity is often exacerbated in ...

Please provide your email address to receive an email when new articles are posted on . Mycobacterial disease incidence was significantly higher among patients with vs. without allergic disease.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Please provide your email address to receive an email when new articles are posted on . Microbial diversity was more prevalent in patients with cured vs. treatment-resistant nontuberculosis ...

Researchers determined the prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) in 2020. The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease ...

Global pharmaceutical major Lupin Limited has entered into a strategic collaboration with TB Alliance to advance the clinical development and commercialization of the investigational drug Telacebec, ...

DENVER (May 9, 2024) – Experts in mycobacterial diseases at National Jewish Health, in collaboration with local health departments and the Centers for Disease Control and Prevention (CDC), are ...

The absence of a single immune cell receptor has been linked to both fewer defenses against mycobacterial infections, such as TB, and damaging buildup of sticky residue in the lungs. The macrophage is ...

Lupin and TB Alliance join forces to advance Telacebec to treat tuberculosis and other mycobacterial diseases: Our Bureau, Mumbai Monday, February 2, 2026, 13:45 Hrs [IST] Global ...

Lupin partners with TB Alliance to develop and commercialize Telacebec for treating tuberculosis and related diseases globally.

Lupin announced a strategic collaboration with TB Alliance, to advance the clinical development and commercialization of Telacebec for the treatment of mycobacterial diseases, such as tuberculosis (TB ...